BIOMAT Database Logo BIOMAT Database Logo

Limited efficacy of an inactivated feline immunodeficiency virus vaccine. 2006

S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Institute of Comparative Medicine, Faculty of Veterinary Medicine, University of Glasgow, Bearsden Road, Glasgow G61 1QH.

UI MeSH Term Description Entries
D002415 Cats The domestic cat, Felis catus, of the carnivore family FELIDAE, comprising over 30 different breeds. The domestic cat is descended primarily from the wild cat of Africa and extreme southwestern Asia. Though probably present in towns in Palestine as long ago as 7000 years, actual domestication occurred in Egypt about 4000 years ago. (From Walker's Mammals of the World, 6th ed, p801) Felis catus,Felis domesticus,Domestic Cats,Felis domestica,Felis sylvestris catus,Cat,Cat, Domestic,Cats, Domestic,Domestic Cat
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013047 Specific Pathogen-Free Organisms Animals or humans raised in the absence of a particular disease-causing virus or other microorganism. Less frequently plants are cultivated pathogen-free. Pathogen-Free Organisms,Specific Pathogen Free,Organism, Pathogen-Free,Organism, Specific Pathogen-Free,Organisms, Pathogen-Free,Organisms, Specific Pathogen-Free,Pathogen Free Organisms,Pathogen Free, Specific,Pathogen Frees, Specific,Pathogen-Free Organism,Pathogen-Free Organism, Specific,Pathogen-Free Organisms, Specific,Specific Pathogen Free Organisms,Specific Pathogen-Free Organism
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D015164 Vaccines, Inactivated Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins. Inactivated Vaccine,Killed Vaccine,Killed Vaccines,Vaccines, Killed,Inactivated Vaccines,Vaccine, Inactivated,Vaccine, Killed
D016089 Immunodeficiency Virus, Feline A species of LENTIVIRUS, subgenus feline lentiviruses (LENTIVIRUSES, FELINE) isolated from cats with a chronic wasting syndrome, presumed to be immune deficiency. There are 3 strains: Petaluma (FIP-P), Oma (FIP-O) and Puma lentivirus (PLV). There is no antigenic relationship between FIV and HIV, nor does FIV grow in human T-cells. FIV,FTLV,Feline Immunodeficiency Virus,Feline T-Lymphotropic Lentivirus,Lentivirus, Puma,Puma lentivirus,Feline T-Lymphotropic Virus,Feline Immunodeficiency Viruses,Feline T Lymphotropic Lentivirus,Feline T Lymphotropic Virus,Lentivirus, Feline T-Lymphotropic,T-Lymphotropic Lentivirus, Feline,T-Lymphotropic Virus, Feline
D016181 Feline Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs in cats infected with feline immunodeficiency virus (FIV) and in some cats infected with feline leukemia virus (FeLV). AIDS, Feline,FAIDS,Feline AIDS,Feline Acquired Immune Deficiency Syndrome,Feline Acquired Immuno-Deficiency Syndrome,Feline Acquired Immuno Deficiency Syndrome
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D019562 Viral Load The quantity of measurable virus in a body fluid. Change in viral load, measured in plasma, is sometimes used as a SURROGATE MARKER in disease progression. Viral Burden,Virus Titer,Burden, Viral,Load, Viral,Titer, Virus

Related Publications

S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Efficacy of an inactivated feline leukemia virus vaccine.
March 1996, AIDS research and human retroviruses,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.
November 1991, Journal of the American Veterinary Medical Association,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Efficacy and safety of a feline immunodeficiency virus vaccine.
December 2004, Animal health research reviews,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Development and testing of an inactivated feline leukemia virus vaccine.
November 1995, Seminars in veterinary medicine and surgery (small animal),
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Feline immunodeficiency virus vaccine issues.
April 2005, Australian veterinary journal,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Feline immunodeficiency virus vaccine issues.
January 2005, Australian veterinary journal,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.
February 2014, Vaccine,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.
March 2008, Clinical and vaccine immunology : CVI,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
November 1991, Journal of the American Veterinary Medical Association,
S P Dunham, and J Bruce, and S MacKay, and M Golder, and O Jarrett, and J C Neil
Vaccine protection against feline immunodeficiency virus.
August 2007, Australian veterinary journal,
Copied contents to your clipboard!